Merely 4 out of 10 retail pharmacies in the U.S. stock buprenorphine, with availability even more restricted in Black and Latino populations, recent UC Berkeley findings reveal.

The article Although prescribing regulations have been eased, opioid addiction treatment remains difficult to locate at pharmacies was initially published on Berkeley News.